Detalhe da pesquisa
1.
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial.
Lancet
; 401(10373): 281-293, 2023 01 28.
Artigo
Inglês
| MEDLINE | ID: mdl-36566761
2.
Early HIV viral suppression associated with subsequent 12-month treatment success among people living with HIV in South Africa.
HIV Med
; 2024 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38488308
3.
Impact of Point-of-Care Testing on the Management of Sexually Transmitted Infections in South Africa: Evidence from the HVTN702 Human Immunodeficiency Virus Vaccine Trial.
Clin Infect Dis
; 76(5): 881-889, 2023 03 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36250382
4.
Inhaled Budesonide for COVID-19 in People at Higher Risk of Complications in the Community: The UK National Community Randomi.
Ann Fam Med
; (21 Suppl 1)2023 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36944089
5.
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
Lancet
; 398(10303): 843-855, 2021 09 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34388395
6.
Point-of-Care HIV Viral Load Testing: an Essential Tool for a Sustainable Global HIV/AIDS Response.
Clin Microbiol Rev
; 32(3)2019 06 19.
Artigo
Inglês
| MEDLINE | ID: mdl-31092508
7.
Acceptability of point-of-care viral load testing to facilitate differentiated care: a qualitative assessment of people living with HIV and nurses in South Africa.
BMC Health Serv Res
; 20(1): 1081, 2020 Nov 25.
Artigo
Inglês
| MEDLINE | ID: mdl-33239012
8.
Clinic flow for STI, HIV, and TB patients in an urban infectious disease clinic offering point-of-care testing services in Durban, South Africa.
BMC Health Serv Res
; 18(1): 363, 2018 05 11.
Artigo
Inglês
| MEDLINE | ID: mdl-29751798
9.
Inclusion and diversity in the PRINCIPLE trial.
Lancet
; 397(10291): 2251-2252, 2021 06 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34119064
10.
Urine tenofovir and dried blood spot tenofovir diphosphate concentrations and viraemia in people taking efavirenz and dolutegravir-based antiretroviral therapy.
AIDS
; 38(5): 697-702, 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38126342
11.
Clinical outcomes with second-line dolutegravir in people with virological failure on first-line non-nucleoside reverse transcriptase inhibitor-based regimens in South Africa: a retrospective cohort study.
Lancet Glob Health
; 12(2): e282-e291, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38142692
12.
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes.
J Infect
; 88(4): 106130, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38431155
13.
Cost-utility analysis of molnupiravir plus usual care versus usual care alone as early treatment for community-based adults with COVID-19 and increased risk of adverse outcomes in the UK PANORAMIC trial.
Br J Gen Pract
; 2024 Jan 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38228357
14.
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients.
Nat Commun
; 15(1): 1652, 2024 Feb 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38396069
15.
Delivery of Community-based Antiretroviral Therapy to Maintain Viral Suppression and Retention in Care in South Africa.
J Acquir Immune Defic Syndr
; 93(2): 126-133, 2023 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36796353
16.
Implementation and outcomes of dolutegravir-based first-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study.
Lancet HIV
; 10(5): e284-e294, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37001536
17.
Clinical outcomes after extended 12-month antiretroviral therapy prescriptions in a community-based differentiated HIV service delivery programme in South Africa: a retrospective cohort study.
J Int AIDS Soc
; 26(9): e26164, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37767825
18.
Point-of-Care Viral Load Testing to Manage HIV Viremia During the Rollout of Dolutegravir-Based ART in South Africa: A Randomized Feasibility Study (POwER).
J Acquir Immune Defic Syndr
; 93(5): 403-412, 2023 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37120720
19.
Clinical outcomes after the introduction of dolutegravir for second-line antiretroviral therapy in South Africa: a retrospective cohort study.
medRxiv
; 2023 Jul 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37461582
20.
Diagnostic accuracy of a point-of-care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz-based antiretroviral therapy.
J Int AIDS Soc
; 26(9): e26172, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37735860